Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Topics Economy

2 Momentum Stocks with Solid Fundamentals and 1 We Turn Down

November 21, 2025

Tandem Diabetes’ third quarter was marked by improved operational efficiency and commercial execution, resulting in a positive market reaction. Management credited the quarter’s performance to the...

Topics Economy

5 Insightful Analyst Questions From Tandem Diabetes’s Q3 Earnings Call

November 13, 2025

Topics Earnings

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors

November 12, 2025

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Topics Artificial Intelligence Stocks

Tandem Mobi Receives FDA Clearance for Use with Android Smartphones

November 10, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

3 Russell 2000 Stocks We Think Twice About

November 09, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 20.3% in the afternoon session after the company reported third-quarter results that surpassed analyst expectations for...

Why Is Tandem Diabetes (TNDM) Stock Soaring Today

November 07, 2025

The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

These stocks are gapping in today's session ↗

November 07, 2025

Via Chartmill

TNDM Q3 Deep Dive: Commercial Transformation and New Product Initiatives Drive Results

November 07, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.6% year on year to $249.3 million. Its GAAP loss...

Tandem Diabetes Care (TNDM) beat Q3 2025 earnings and revenue estimates, driving a 16% stock surge. The company reported strong sales growth and improved margins.

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

Tandem Diabetes Care Inc (NASDAQ:TNDM) Surpasses Q3 2025 Expectations, Stock Soars ↗

November 06, 2025

Via Chartmill

What's going on in today's after hours session ↗

November 06, 2025

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Tandem Diabetes (NASDAQ:TNDM) Beats Expectations in Strong Q3, Stock Jumps 17.5%

November 06, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $249.3 million. Its GAAP loss...

Tandem Diabetes Care Announces Third Quarter 2025 Financial Results

November 06, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.1% in the morning session after analyst projections for its third-quarter 2025 earnings pointed to a year-on-year revenue...

Why Tandem Diabetes (TNDM) Shares Are Plunging Today

November 06, 2025

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Topics Artificial Intelligence

November 05, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Tandem Diabetes Earnings: What To Look For From TNDM

November 04, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings this Thursday after the bell. Here’s what to expect.

Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards

Topics Artificial Intelligence

November 04, 2025

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

November 02, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Why Tandem Diabetes (TNDM) Shares Are Getting Obliterated Today

October 31, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor concerns were sparked by a disappointing financial outlook from peer DexCom....

Topics Supply Chain

Tandem Diabetes Care Announces Upcoming Conference Presentations

October 31, 2025

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

October 30, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States

October 29, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 1.6% in the afternoon session after the company announced a positive update on a clinical study for its Control-IQ...

Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know

October 28, 2025

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

Topics Economy Government World Trade

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor ↗

October 28, 2025

Via Benzinga

Topics Death Lawsuit

Healthcare Technology Stocks Q2 Highlights: Tandem Diabetes (NASDAQ:TNDM)

October 26, 2025

Looking back on healthcare technology stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Tandem Diabetes (NASDAQ:TNDM) and its peers.

Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDM

October 16, 2025

From The Rosen Law Firm, P.A.